

Psychedelics, Metaplasticity, Critical Periods, Social Learning, Psilocybin, LSD, MDMA, Ketamine, Ibogaine & Neuroscience | Gül Dölen | 121
64 snips Jul 19, 2023
In a captivating discussion, Gül Dölen, a pioneering neuroscientist from Johns Hopkins University, delves into the fascinating world of psychedelics and their impact on mental health. She explains how substances like LSD and psilocybin open critical periods in brain development, enhancing social learning and plasticity. Gül contrasts these non-addictive drugs with traditional addictions, emphasizing their potential for therapeutic applications. The conversation also highlights the evolving landscape of psychiatry and the need for context in psychedelic treatments.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8 9
Intro
00:00 • 5min
Neuroscience of Addiction and Plasticity
04:32 • 10min
Psychedelics and Neuroplasticity
14:36 • 17min
Reopening Critical Periods: The Role of Psychedelics
31:19 • 26min
Psychedelics and Brain Plasticity
57:12 • 26min
Psychedelics in Psychiatry: Challenges and Considerations
01:23:12 • 7min
Exploring Critical Periods and Behavior in Rodent Neurology
01:30:32 • 2min
Mental Health and Modern Connection
01:32:20 • 9min
Exploring Future Research and a Metabolic Health Device
01:40:55 • 2min